A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy—a fundamental breakthrough. The research, published in Cell Reports Medicine, was led by Dr. Arshad Ayyaz, Ph.D., an assistant professor in the Department of Biological Sciences and a member of the Arnie Charbonneau Cancer Institute.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗